(Q38337013)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

review article

2 references

25 October 2022

The Role of Interferon-λ Locus Polymorphisms in Hepatitis C and Other Infectious Diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Clark D Russell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Cory M Dunnigan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jürgen G Haas

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

23 January 2015

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

25 October 2022

Journal of Innate Immunity

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

25 October 2022

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

231-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus

29 February 2020

cites work

1 reference

12 December 2020

Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis.

1 reference

12 December 2020

Interferon-λs: special immunomodulatory agents and potential therapeutic targets.

1 reference

12 December 2020

IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients

1 reference

12 December 2020

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance

1 reference

12 December 2020

The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors

1 reference

12 December 2020

IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection

1 reference

12 December 2020

The anticancer face of interferon alpha (IFN-alpha): from biology to clinical results, with a focus on melanoma

1 reference

12 December 2020

Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense

1 reference

12 December 2020

The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleuk

1 reference

12 December 2020

IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression

1 reference

12 December 2020

Chronic viral hepatitis and the human genome

1 reference

12 December 2020

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

1 reference

12 December 2020

Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling

1 reference

12 December 2020

IL-29 and IFNα differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNγ receptor expression

1 reference

12 December 2020

Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C

1 reference

12 December 2020

Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex

1 reference

12 December 2020

IL28B single-nucleotide polymorphism rs12979860 is associated with spontaneous HIV control in white subjects

1 reference

12 December 2020

Profiling the expression of interleukin (IL)-28 and IL-28 receptor α in systemic lupus erythematosus patients.

1 reference

12 December 2020

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

1 reference

12 December 2020

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

12 December 2020

Lambda interferon inhibits hepatitis B and C virus replication

1 reference

12 December 2020

The cryptic interplay between systemic lupus erythematosus and infections

1 reference

12 December 2020

Association analyses identifying two common susceptibility loci shared by psoriasis and systemic lupus erythematosus in the Chinese Han population

1 reference

12 December 2020

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

12 December 2020

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

1 reference

12 December 2020

Interferon lambda genetic polymorphisms and viral infection: the tip of the iceberg?

1 reference

12 December 2020

Role of deficient type III interferon-λ production in asthma exacerbations

1 reference

12 December 2020

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases

1 reference

12 December 2020

Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity

1 reference

12 December 2020

Regulation of IFN-λ1 promoter activity (IFN-λ1/IL-29) in human airway epithelial cells.

1 reference

12 December 2020

IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B.

1 reference

12 December 2020

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

1 reference

12 December 2020

Interferon lambda 1-3 expression in infants hospitalized for RSV or HRV associated bronchiolitis

1 reference

12 December 2020

SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap

1 reference

12 December 2020

IL-28 elicits antitumor responses against murine fibrosarcoma

1 reference

12 December 2020

Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer

1 reference

12 December 2020

IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population

1 reference

12 December 2020

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity

1 reference

12 December 2020

Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office

1 reference

12 December 2020

Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts

1 reference

12 December 2020

Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response.

1 reference

12 December 2020

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses

1 reference

12 December 2020

Evaluation of the relationship between IL28B, IL10RB and IL28RA single-nucleotide polymorphisms and susceptibility to hepatitis C virus in Chinese Han population

1 reference

12 December 2020

Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth

1 reference

12 December 2020

Hepatic interferon-stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin-28B genotypes

1 reference

12 December 2020

The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

1 reference

12 December 2020

Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections

1 reference

12 December 2020

IL28B polymorphism correlates with active hepatitis in patients with HBeAg-negative chronic hepatitis B.

1 reference

12 December 2020

Regulation of interferon lambda-1 (IFNL1/IFN-λ1/IL-29) expression in human colon epithelial cells

1 reference

12 December 2020

IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease

1 reference

12 December 2020

Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages

1 reference

12 December 2020

IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients.

1 reference

12 December 2020

A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication

1 reference

12 December 2020

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

1 reference

12 December 2020

The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs

1 reference

12 December 2020

IFNL4-ΔG genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirin

1 reference

12 December 2020

The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients

1 reference

12 December 2020

Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells

1 reference

12 December 2020

Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial.

1 reference

12 December 2020

Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism

1 reference

12 December 2020

Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.

1 reference

12 December 2020

Genetic variation of the IL-28B promoter affecting gene expression

1 reference

12 December 2020

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

12 December 2020

Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies

1 reference

12 December 2020

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo

1 reference

12 December 2020

Pretreatment prediction of the outcome of response-guided peginterferon-α and ribavirin therapy for chronic hepatitis C.

1 reference

12 December 2020

The recent breakthroughs in the understanding of host genomics in hepatitis C.

1 reference

12 December 2020

Genetic variations in IL28B and allergic disease in children

1 reference

12 December 2020

Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis.

1 reference

12 December 2020

Genetics of IL28B and HCV--response to infection and treatment

1 reference

12 December 2020

IFN-lambda determines the intestinal epithelial antiviral host defense

1 reference

12 December 2020

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C.

1 reference

12 December 2020

IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.

1 reference

12 December 2020

Interferon-lambda serum levels in hepatitis C.

1 reference

12 December 2020

IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity

1 reference

12 December 2020

IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients.

1 reference

12 December 2020

Paradoxical expression of IL-28B mRNA in peripheral blood in human T-cell leukemia virus type-1 mono-infection and co-infection with hepatitis C virus

1 reference

12 December 2020

Interleukin 28B genetic polymorphism and hepatitis B virus infection

1 reference

12 December 2020

Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.

1 reference

12 December 2020

Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population

1 reference

12 December 2020

Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses

1 reference

12 December 2020

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo

1 reference

12 December 2020

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

12 December 2020

Relationship between polymorphisms near the IL28B gene and spontaneous HBsAg seroclearance: a systematic review and meta-analysis

1 reference

12 December 2020

Significance of miRNA-122 in chronic hepatitis C patients with serotype 1 on interferon therapy

1 reference

12 December 2020

Comparative analysis of rs12979860 SNP of the IFNL3 gene in children with hepatitis C and ethnic matched controls using 1000 Genomes Project data

1 reference

12 December 2020

Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics

1 reference

12 December 2020

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

1 reference

12 December 2020

Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms

1 reference

12 December 2020

Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B

1 reference

12 December 2020

Rare variants create synthetic genome-wide associations

1 reference

12 December 2020

Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?

1 reference

12 December 2020

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

12 December 2020

Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells

1 reference

12 December 2020

CD14+ cell-derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation

1 reference

12 December 2020

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

12 December 2020

Human genetic susceptibility to infectious disease

1 reference

12 December 2020

HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B.

1 reference

12 December 2020

Stratified infection medicine: a call to arms

1 reference

12 December 2020

Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo

1 reference

12 December 2020

HHV-6B induces IFN-lambda1 responses in cord plasmacytoid dendritic cells through TLR9

1 reference

12 December 2020

Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus.

1 reference

12 December 2020

Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection

1 reference

12 December 2020

Potential anti-tumor effect of IFN-λ2 (IL-28A) against human lung cancer cells

1 reference

12 December 2020

Identifiers

DOI

10.1159/000369902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25634147%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference